We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
+23.63%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$155M
AUM Growth
-$18.5M
Cap. Flow
-$27.7M
Cap. Flow %
-17.88%
Top 10 Hldgs %
99.95%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$24.7M
2
AVIR icon
Atea Pharmaceuticals
AVIR
+$3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVIR icon
1
Atea Pharmaceuticals
AVIR
$420M
$57.4M 37.04%
1,637,331
-108,000
-6% -$3M
KYMR icon
2
Kymera Therapeutics
KYMR
$8.94B
$37.5M 24.22%
639,059
– –
SEER icon
3
Seer Inc
SEER
$120M
$28.2M 18.19%
816,375
– –
APLS
4
DELISTED
Apellis Pharmaceuticals
APLS
$20.6M 13.29%
624,962
-440,000
-41% -$24.7M
STRO icon
5
Sutro Biopharma
STRO
$421M
$3.31M 2.13%
17,500
– –
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$3.09M 1.99%
12,438
– –
CLSD
7
DELISTED
Clearside Biomedical
CLSD
$1.76M 1.14%
19,570
– –
MTEM
8
DELISTED
Molecular Templates, Inc.
MTEM
$1.37M 0.89%
13,654
– –
KZR
9
DELISTED
Kezar Life Sciences
KZR
$1.11M 0.72%
12,892
– –
RNTX
10
Rein Therapeutics
RNTX
$69.9M
$528K 0.34%
25,878
– –
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$75K 0.05%
25,651
– –

Similar funds

LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
OGC
One68 Global Capital New York $30.9M AUM
AC
ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return
PL
Protective Life Birmingham, Alabama $30.1M AUM 0.65% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return

AJU IB Investment Company's Q3 2021 Portfolio in Review

As of Q3 2021, AJU IB Investment Company held 11 positions worth $155M, down 11% from $173M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AJU IB Investment Company withdrew a net $27.7M in Q3 2021, reducing 2 holdings. Its largest reduction was Apellis Pharmaceuticals, cutting an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company's biggest Q3 2021 reduction was Apellis Pharmaceuticals, cutting an estimated $24.7M.
  • AJU IB Investment Company's ten largest holdings make up 100% of its $155M portfolio in Q3 2021.
  • AJU IB Investment Company opened 0 new positions and closed 0 in Q3 2021.
  • AJU IB Investment Company's portfolio value fell 11% quarter-over-quarter to $155M.

Based on AJU IB Investment Company's 13F filing for Q3 2021, filed 10 Nov 2021.